Disappearance of angina pectoris by lipid-lowering in type III hyperlipoproteinemia

American Journal of Cardiology

Volumn 107, Issue 5, 2011, Pages 793-796

  Cho, Eun Jeung ^a   Min, Yun Joo ^a   Oh, Min Seok ^a   Kwon, Jee Eun ^a   Kim, Jeung Eun ^a   Kim, Chee Jeong ^a  

^a Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN E2; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; FENOFIBRATE; LIPID; NITRATE; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROPHORESIS; FEMALE; GENOTYPE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; LIPID BLOOD LEVEL; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; T WAVE INVERSION; THORAX PAIN; TREADMILL EXERCISE; XANTHOMA;

ANGINA PECTORIS; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FENOFIBRATE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; HYPERLIPOPROTEINEMIA TYPE III; HYPOLIPIDEMIC AGENTS; MIDDLE AGED; PYRROLES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79951576715     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.10.063     Document Type: Article

References (10)

1. P.T. Kuo, A.C. Wilson, J.B. Kostis, A.B. Moreyra, and H.T. Dodge Treatment of type III hyperlipoproteinemia with gemfibrozil to retard progression of coronary artery disease Am Heart J 116 1988 85 90
2. M.A. Kawashiri, T. Higashikata, M. Takata, S. Katsuda, K. Miwa, A. Nohara, A. Inazu, J. Kobayashi, M. Shimizu, J. Koizumi, and H. Mabuchi Type III hyperlipoproteinemia exaggerated by Sheehan's syndrome with advanced systemic atherosclerosis: a 28-year clinical course Circ J 69 2005 746 751 (Pubitemid 40806116)
3. H.B. Brewer Jr, L.A. Zech, R.E. Gregg, D. Schwartz, and E.J. Schaefer NIH conference Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment Ann Intern Med 98 1983 623 640 (Pubitemid 13091177)
4. P.N. Hopkins, L.L. Wu, S.C. Hunt, and E.A. Brinton Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease J Am Coll Cardiol 45 2005 1003 1012 (Pubitemid 40432430)
5. M. van Dam, M. Zwart, F. de Beer, A.H.M. Smelt, M.H. Prins, M.D. Trip, L.M. Havekes, P.J. Lansberg, and J.J.P. Kastelein Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia Heart 88 2002 234 238 (Pubitemid 34913502)
6. S. Lussier-Cacan, J.M. Bard, L. Boulet, A.C. Nestruck, A.M. Groth, J.C. Fruchart, and J. Davignon Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III Atherosclerosis 78 1989 167 182 (Pubitemid 19195487)
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
8. D.R. Illingworth, and J.P. O'Malley The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia Metabolism 39 1990 403 409 (Pubitemid 20146593)
9. G. Feussner, M. Eichinger, and R. Ziegler The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipidemia Clin Invest 70 1992 1027 1035
10. R.L. Ellen, and R. McPherson Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia Am J Cardiol 81 1998 60B 65B (Pubitemid 28113948)